Our objective is to develop smart, efficient, cost-effective, and sustainable processes that enable our clients to treat disease more rapidly and benefit patients worldwide. Our services efficiently and effectively enable our clients to progress through pre-clinical and into the clinical phases to register, validate, and ultimately commercialize their NCEs.
Our scientists, supported by dedicated project managers, ensure the provision of our multi-faceted services in a compliant and timely manner; incorporating process development and optimization while anticipating scale-up issues with a systematic approach including Quality by Design methods and the effective use of formal risk management processes to define and steer the product control strategy.
There are very few chemistry challenges we have not experienced at some point, and our expertise includes:
“With a Motivational and extremely supportive management, we have access to the latest technologies and Chemistry, whereby we can work on new products and improved processes, contributing to Company’s mission to 'save lives' with quality drugs for all humans.”
Dr. Ravikesh Yadav – General Manager - R&D DCAL India
© 2023 Dishman Carbogen Amcis Ltd - All Rights Reserved